| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |